18 ms·
How to Avoid a Post-Antibiotic World
- halestock 10y agoIn its apparent desire to blame Congress for the end of antibiotics, this article misses a big reason companies aren't developing new antibiotics anymore: they just don't work like they used to. Every new generation of antibiotic is effective for a shorter period than the previous.
- JumpCrisscross 10y agoDo you have a source for this alleged temporal decay of efficacy?
- asdfasdfa11112 10y agoIf you are serious with your question, instead of just trying to jockey for hacker forum dominance, a very quick google search will answer your question. It is possible that I misunderstood your Q, and your tone, and if so, I apologize. I searched google.com for "increased antibiotic resistance over time" and found two sources that seem pretty legit. One is the World Health Organization, the other is the US National Library of Medicine. Both articles appear to address the question I believe you raised. [0] http://www.who.int/mediacentre/factsheets/fs194/en/ http://www.who.int/mediacentre/factsheets/fs194/en/ [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
- JumpCrisscross 10y agoThank you! My key question was less around increasing numbers of antibiotic-resistant pathogens and more toward the claim that antibiotics released today produce resistant strains faster than ones produced say fifty years ago. The timeline in your second link should help me piece that together...
- melling 10y agoThey should be blaming doctors and people for using them incorrectly. Doctors used to give them to people because they had a cold, for example. People insisted on being given some sort of medicine. In India, you can still buy antibiotics over the counter. http://www.npr.org/sections/goatsandsoda/2015/09/17/441146398/why-india-is-a-hotbed-of-antibiotic-resistance-and-sweden-is-not http://www.npr.org/sections/goatsandsoda/2015/09/17/44114639...
- douche 10y agoUnfortunately, that does work in most cases. I'm curious what the success rates would be if all zithromax (?) prescriptions were replaced with sugar pills. I've gotten that drug many times for what may or may not have been strep or bronchitis.
- Fomite 10y agoThere is actually a company doing this. They were handing out samples at IDWeek. It's called the "ZeePack" or something of the sort (a play on the the azithromycin/zithromax 'Z-Pak') and is essentially vitamins and herbal supplements you can give to cold patients so they feel like they have been given something.
- rscho 10y agoThe "success" rate would still be very high, as most people would surmount the infection. However, the "failure" rate (people dying) would be much higher as well... I am sure you can see that would be an ethical and practical problem. Where would you put the "safety" cutoff of not giving zithromax?
- douche 10y agoReally, what are the rates on people dying from tier 1 infections like that
- rscho 10y agohttps://www.cdc.gov/mmwr/preview/mmwrhtml/mm4829a1.htm https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4829a1.htm That kind of rates. In the 1918 influenza pandemics for example, many people died of a bacterial pneumonia following the flu infection. So you see, the impact of "1-tier" infections is very real without antibiotics. EDIT: by all means, downvoters, make your point explicit!
- Fomite 10y agoThis will come as a surprise to Merck, which recently bought Cubist to boost their antibiotics research arm, and which is actively funding research in that area. Or GSK, which has partnered with a bunch of European universities to develop new antibiotics against gram negatives.
- thephyber 10y agoI don't think it will "come as a surprise" to any major public pharma company. They are all in the business of managing risk: * that a drug test will fail trials * that they will be beat to market by a competing drug * that a contamination in their products will cause damage to patients * that R&D costs will not be recovered before the patent expires * keeping R&D costs low enough to be competitive, but high enough to have a pipeline of future products IIRC, general antibiotics have never lasted more than 18 months before we found a bacteria that became resistant to them. Pharma companies know this more than the rest of us. They are betting/hedging on getting to market first with a multi-drug resistant (MDR) bug killer. Everyone on Earth will need a new antibiotic as the current MDR bugs become more widespread. And the more widespread the current MDR bugs are, the more valuable a fresh antibiotic would be (it would be an effective monopoly).
- refurb 10y agogeneral antibiotics have never lasted more than 18 months before we found a bacteria that became resistant to them But this doesn't mean the drug won't be used. Drug resistance rates are often in the single percent of patients. You can have resistance out there, but still have a huge market.
- Fomite 10y ago18 months is the time until any resistance is found, but that doesn't mean we hang up the antibiotic. We do susceptibility testing, we use higher doses, we use combination therapy, etc. Resistance is a continuum, not a binary state.
- greeneggs 10y ago> IIRC, general antibiotics have never lasted more than 18 months before we found a bacteria that became resistant to them. This does not seem to be correct. With the most recently introduced antibiotics—Levoflaxacin, Linezolid and Ceftaroline—resistance has developed very rapidly. But that didn't used to be the case; old antibiotics lasted much longer before resistance developed. [1] I am not sure why this is---are these newer antibiotics more fragile (i.e., easier to resist), or are they being misused more broadly? If it is the latter reason, then perhaps we should stop developing new antibiotics until better usage practices are enforced. It is stupid to spend a lot of money developing antibiotics, only to throw it away by misusing them. [1] http://www.nature.com/nature/journal/v509/n7498_supp/fig_tab/509S2a_G2.html http://www.nature.com/nature/journal/v509/n7498_supp/fig_tab...
- refurb 10y agoAnother big reason is the lack of financial incentives for companies. A lot of new antibiotics are for very small populations (you'll only use a new antibiotics for the rare cases of drug resistance). As a result, drug companies are looking at spending $100M to make a new drug, when they'd be lucky to make their money back on it.
- Swannie 10y agoSadly I read this as a thinly veiled attempt to argue for Congress to fund anti-bioitic research. Why? Well the article practically spells out the why: pharma is not incentivised to bring new anti-biotics to market, but they can create lots of "new" ones that are similar to the old ones. Why not change the model, and create a system where pharma companies can churn out "new and innovative" anti-biotics, for a nice guaranteed government payout. "Win win" for pharma, politicians, and who knows - maybe farmers and people? Cynical? Extremely. An element of truth in my view? Almost certainly. The way I view it - we have too many different options available on the market. We should look to remove a decent % of them from circulation in as many countries as possible, to allow any resistant strains to lose their resistance. Yes, this would impact pharma companies, but their could be a rotational system with extensions to patents as required to keep them happy.
- cstejerean 10y agoTime to stimulate research into phage therapy instead of granting longer patents to antibiotics. The field seems promising with a long history in Russia but mostly ignored in the west until recently. https://en.m.wikipedia.org/wiki/Phage_therapy https://en.m.wikipedia.org/wiki/Phage_therapy
- toodlebunions 10y agoPhage therapy is expensive and time consuming, unique to each patient and bacteria. It'd be a tool, but not a broad solution.
- kchoudhu 10y agoBeats dying. Which is the alternative once antibiotic resistance is total.
- Fomite 10y agoPhages are being researched. This literally comes up in every single HN thread on antibiotics, so once more, posting my "Why Phages Aren't the Answer" shortlist. Note that I love phage therapy - this is the problems as seen by someone who doesn't think it's a dead end. Phage therapy is neat, it really is, but there are a couple major issues: - There is no such thing as a "broad spectrum" phage. You can't do empirical treatment using phages, and there's not really "off the shelf" phage therapy - it tends to be a bespoke creation for a particular infection. - There's some serious regulatory problems, similar to those experienced by fecal transplant treatments. We're not yet really equipped to think about handling evolving, custom microbes as a treatment. - Because of the first, it's going to require a considerable amount more lab capacity than most clinical settings currently have, and considerable delays until treatment. - There's also some biosafety issues around phage prep, but those are easily solvable. It's a great way to treat particularly resistant or hard to treat infections, but it's not a particularly great general solution. There's a reason it was abandoned in countries with easy access to antibiotics - they're just roundly superior in basically every respect.
- danieltillett 10y ago
- deleted 10y ago[deleted]
- gleb 10y agoWe could use a solution from electricity markets. Electricity generation companies are paid not just for the electricity they produce, but also for reserve capacity. Because that's the only way to keep the lights on reliably. Seems like this would work for antibiotics and snake antivenoms. http://www.theenergycollective.com/adamjames/237496/energy-nerd-lunch-break-how-capacity-market-works-and-why-it-matters http://www.theenergycollective.com/adamjames/237496/energy-n...
- rtkwe 10y agoAn electric company doesn't have to invent a new plant design or even build an entirely new plant to have reserves but with antibiotics you do. Building reserve antibiotics isn't simple and even holding back a known antibiotic doesn't guarantee it'll work when you need it. We kind of already do that with carbapenems which are supposed the be the antibiotic of last resort.
- kpil 10y agoYes, but I think I see the analogy. The problem is the commercial model for funding and research, as a new antibiotic is guaranteed to be a commercial failure, and the risks are high. If EU, US and maybe the Chinese funded research - both universities but also in some way that it would be economically interesting for commercial entities, there would be new drugs.
- Fomite 10y ago> a new antibiotic is guaranteed to be a commercial failure This is not axiomatically true.
- aembleton 10y agoIf you develop a new antibiotic then it won't be used, it will be held in reserve for when current antibiotics no longer work. We don't want to expose bacteria to new antibiotics until we have to. This is why it would be a commercial failure. A change to the model where the government(s) develop their own antibiotics so that they can sit on them might be in order. It's not much of a vote winner but is as essential as defence.
- milesf 10y agoFrom this website: http://seqclinic.com/chinese_medicine.html http://seqclinic.com/chinese_medicine.html Historically, a Chinese Medicine doctor was paid a retainer to keep their patients healthy. If a patient became sick, the doctor would not be paid until the patient’s health returned. In a similar vein, a doctor that resorted to surgery was considered an inferior doctor. If he/she did their job correctly and helped their clients stay healthy, there would be no need to perform surgery. Perhaps the current incentive for drug companies is the problem. They don't care if we stay healthy (which is what we all want), they only treat illness. In fact you could argue it's in the best interest of drug companies to keep us sick! Maybe there's an alternative way to fund them, or an alternative way to deal with infections in the first place.
- soohyung 10y agoI don't think that's a very good point. In order for people to be willing to pay the ever-rising costs for the best drugs they are going to have to work, drug companies aren't going to make much money once they've lost the trust of their customers. Perhaps the funding is problematic in one way or another but I doubt it's in drug companies' best interest to keep us sick.
- deleted 10y ago[deleted]
- reddytowns 10y agoIf it takes 5 to 10 years before a drug makes you sick, no one will care. It's all about next quarter
- Retric 10y agoThe increasing cost relates to drug companies running out of useful simple molecules. If you count the number of new drugs that treat common problems aka more than 100,000 people per year in the US and are not closely related to another drug you get a very tiny number of new drugs per year. Sure we have a lot of drugs related to Morphine, but most of them are not significantly different from Morphine as to be worth high prices. When viagra goes generic at the end of the year the hurdle for the next male 'enhancement' drug ratchets up.
- toodlebunions 10y agoThis is a global health crisis waiting to happen. Incentives need to be created for pharma to create many new broad spectrum antibiotics. Longer patents, financial or tax incentives, even subsidies, whatever it takes.
- adventured 10y agoThe solution is already rapidly inbound, few are talking about it for some reason though. Within three or so years, everyone will be talking about the obvious solution to it. You'll see dozens upon dozens of articles pop up in that time, talking about the same thing... For less than $20,000 you can start experimenting with new attacks on infection and resistance, in your kitchen (so to speak; I'd suggest a real lab), using CRISPR. You can order the bacterial samples you need very inexpensively, and just begin working on it. Based on the current legal position of Broad and Berkeley, You can also do any work you want around Cas9 or Cpf1 in the US, without concerns for licensing/patents (until or less you plan to commercialize). Only a few interesting things are out there about it now, that'll change very soon: https://www.ncbi.nlm.nih.gov/pubmed/26502735 https://www.ncbi.nlm.nih.gov/pubmed/26502735 https://www.geneticliteracyproject.org/2016/08/22/crispr-genome-editing-game-changer-war-antibiotic-resistance/ https://www.geneticliteracyproject.org/2016/08/22/crispr-gen...
- umberway 10y agoThere may be a lot of antibiotics present in the soil which haven't been exploited yet because it's hard to grow in the lab the organisms which produce them. However techniques are being developed to circumvent this problem and here's an early discovery: https://en.wikipedia.org/wiki/Teixobactin https://en.wikipedia.org/wiki/Teixobactin Hopefully other and fundamentally newer ways to fight infection will be found. In the mean time getting fit and healthy now seems like a slightly wiser choice than it already was.
- candiodari 10y agoI don't think this is true. When we initially found out about antibiotics, in about 15 years we got to about 5 working general purpose antibiotics (general = works against pretty much every pathogen). Since then we've found 1 more, in over 70 years. Even if this new drug turns out to be a total success, counting on finding new drugs in the near future seems to be an extremely long shot. It's not going to happen. Rates of discovery predict availability of future drugs. Furthermore the rate at which bacteria adapt to drugs has also increased. Adaptation happens faster and faster. While I don't know how that applies to this particular drug, a naive extrapolation would seem to indicate it won't last half a decade.
- guftagu 10y agoThat is completely false. Just a Google search will reveal to you that dozens of new antibiotics have been found since but they didn't last long. BTW, Penicillin also lasted less than a year before bacteria developed resistance to it.
- candiodari 10y agoWell it's not false once you consider that those "dozens" are tiny variations of the existing ones.
- lbarrett 10y agoThe overuse of antibiotics in large-scale animal farming is particularly terrible; many are given low doses of antibiotics as part of their food [1]. This gives bacteria lots of time and selective breeding to become resistant, and it's probably the worst thing we could do for the long-term health of humanity. [1] https://en.wikipedia.org/wiki/Antibiotic_use_in_livestock#United_States https://en.wikipedia.org/wiki/Antibiotic_use_in_livestock#Un...
- candiodari 10y agoThe thing to note, however, is that once the horse is out of the barn, closing the barn door is futile. In fact it may very well be counterproductive if it leads to infected meat spreading further.
- Fomite 10y agoSaid antibiotics are most often used for growth promotion, rather than to treat disease. That's becoming less common, but it's still a complex problem.
- curun1r 10y agoYes and no. Said antibiotics are given because we know that the diet we're feeding them will cause them to develop infections. Cows aren't naturally healthy eating corn/soy. For so many reasons, we need to end crop subsidies in this country.
- jmartinpetersen 10y agoIt's been known since the 50's that giving penicillin to livestock increases growth rate. Farmers have understood that and used that. The antibiotics counters and interacts in all sorts of ways we don't really understand (similar to how we don't really, really understand how the human gut works), but one of the ways it surely works is to counter problems caused by unsuitable living conditions. Ending crop subsidies is probably a good idea in most of the world, but it certainly won't solve the overuse of antibiotics in agriculture.
- veerjaya33 10y agohttps://www.youtube.com/watch?v=vpSVqpxWwzs https://www.youtube.com/watch?v=vpSVqpxWwzs kamjor dil wale na dekhe
- veerjaya33 10y agohttps://www.youtube.com/watch?v=vpSVqpxWwzs https://www.youtube.com/watch?v=vpSVqpxWwzs
- nradov 10y agoIn evolving resistance to multiple antibiotics do bacteria tend to become weaker or less fit in other ways? I would think there must be some trade offs involved if they can no longer use certain molecules in their cell walls or metabolic pathways. Or to put it another way, if there are resistant and non-resistant bacteria in a particular environment will the non-resistant population tend to out compete the resistant population in the absence of antibiotics?
- jorgemf 10y agoEvolution is part of life, while some bacterias adapt to the antibiotics there are other animals (fungus, bacterias,...) that try to compete with them, and usually they find the ways to kill each other. It is part of evolution, but evolution takes time, and discover this new mechanism also takes time. So by the time we discover a new antibiotic it can be too late for a lot of people.
- majkinetor 10y agoMicroevolution doesn't take that much human time to be honest.
- jorgemf 10y agoBut it doesn't happen as you would want. The bacteria evolves fast but it doesn't mean they will create antibiotics for other bacterias. You have to be in the right place at the right moment. And them wait a lot of years until you can use that antibiotic in the human race.
- jakobegger 10y agoYes, resistance to antibiotics comes with a cost. There are several mechanisms for antibiotic resistance. For example, the bacteria could produce a protein that pumps the antibiotic out of the cell. Producing this protein is expensive, so in the absence of antibiotics, bacteria tend to lose the genes responsible for it.
- Fomite 10y ago
- amorphid 10y agoIt'll be interesting to see if/when a non-antibiotic solution to killing bacteria comes along. I read about an approach a novel approach a couple months ago that uses a polymer to destroy bacteria.[1] I'm not qualified to comment on the merits of the science. [1] http://inhabitat.com/student-discovers-a-way-to-destroy-superbug-bacteria-without-antibiotics/ http://inhabitat.com/student-discovers-a-way-to-destroy-supe...
- sengork 10y agoThere are a few of those non-antibiotic based approaches discussed in the following BBC Horizon programme: http://www.bbc.co.uk/programmes/b01ms5c6 http://www.bbc.co.uk/programmes/b01ms5c6
- vivekd 10y ago>Although the patent system is good at producing new blood-pressure medications and cardiovascular drugs, it’s not the right fit for antibiotics. I don't know if I want to get into an arms race with microbes where we keep trying to discover new antibodies only to have them develop resistance. Maybe the better solution is to limit antibiotics only to life threatening situations and let people build up their natural resistance.
- whack 10y agoThe article seems to have thrown in the towel with regard to existing antibiotics, which seems like a waste since there's so much more we could do. Restrict antibiotics the same way we restrict morphines. Censure doctors who over prescribe antibiotics, when they aren't needed. Do not allow them to be used in animal feed for any reason. We're talking about a vital resource that can save millions of lives. Allowing this resource to be depleted by frivolous use, is downright criminal.
- cdmckay 10y agoThe issue is that it needs to be a global solution. Just changing the rules in the US won't prevent them from being abused in other countries.
- adventured 10y agoChina for example is by far the world's largest abuser of antibiotics [1]. The average person in China is taking ten times the amount of antibiotics annually that the average person in the US takes (and when you consider the number of people in question, it's that much more staggering). You're spot on, in that it's a dramatic challenge, figuring out how to convince a nation like China to tamp down on that given the scale involved (eg a billion people being commonly prescribed antibiotics for a normal cold). [1] http://content.time.com/time/world/article/0,8599,2103733,00.html http://content.time.com/time/world/article/0,8599,2103733,00...
- rwallace 10y agoOther countries have followed the American example with regard to lots of bad policies. They might very well follow it with regard to a good policy. At least trying would be much better than just throwing our hands in the air.
- manquer 10y agowell if the U.S. enforced food import restrictions on antibiotic feed farm food and visa restrictions, the rest of the world will quickly change its tune
- 10y ago
- jahbrewski 10y agoOkay, I've read enough articles on superbugs to be seriously frightened. My question: is there anything I, personally, can do to help?
- lunchladydoris 10y agoThere are two small things you can do: 1. Always finish your course of antibiotics. Even if you're feeling better. The course is as long as it is for a reason. 2. If for some reason you choose not to do (1) above, do not ever give someone what is left over from your course.
- askvictor 10y agoThere is little evidence behind the length of the antibiotic course[1]. Depending on the type of infection, coming off antibiotics early may be better for you (OTOH, this can lead to a bad outcome for you too). [1] https://www.mja.com.au/journal/2015/202/3/knowing-when-stop-antibiotic-therapy https://www.mja.com.au/journal/2015/202/3/knowing-when-stop-...
- DanBC 10y agoAsk your doctor to sign up to antibiotic guardian style schemes. Ask your doctor what happens if you don't take antibiotics - are they really needed for this illness? If you do get antibiotics take the full course. Take them correctly, according to the instructions.
- askvictor 10y agoDon't eat meat, eggs or dairy that use antibiotics in their normal rearing practices (organic is a good alternative, or look for antibiotic free foods, or minimise eating of those altogether). Talk about this with others, in a non confrontational and non judgemental way. Also, don't take antibiotics yourself unless you are certain they are necessary; many infections are non bacterial, and even some bacterial infections can be fought off by your body quite well. Look after your immune system; it looks after you. Ironically, taking antibiotics might negatively impact your immune system due to the impact of the antibiotics on your intestinal floral (mostly bacteria, a lot of which are killed during the course), which are increasingly being linked to healthy immune function.
- Animats 10y agoThe parent article is by two lawyers. Here's a better introductory article by a biochemist.[1] A key point is that there are a finite number of small molecules which can potentially be used as antibiotics. Throwing money at finding them may not work against a depleting resource. [1] http://fire.biol.wwu.edu/cmoyer/zztemp_fire/biol345_F10/papers/Davies_evol_anti_rest_mmbr10.pdf http://fire.biol.wwu.edu/cmoyer/zztemp_fire/biol345_F10/pape...
- lunchladydoris 10y agoAt the individual level, I've always thought of antibiotic misuse as (at least in some part) a symptom of our resistance to authority. People end their antibiotic course early (and then usually use the remaining pills another time) because, of course, they know better. I've run into people like this many times. Now, perhaps doctors should take part of the blame for not explaining why you should finish your course of antibiotics, but users should take some of the responsibility too.
- rwallace 10y agoTo play devil's advocate, since this doesn't seem to get mentioned often: 1. People ending their antibiotic course early is a drop in the ocean compared to the abuse of antibiotics in agriculture. 2. The advice to finish the course was coined back when GPs did house calls. Now, if you use up all your current supply, what do you do next time you get sick? By the time you know you need an antibiotic, you're not going to be well enough to hump your arse across town to petition a doctor for a prescription. The official answer might be to call an ambulance, but the ambulances and hospitals are hopelessly overloaded already, and that's nevermind the situation in the US where a hospital visit can bankrupt you even if you have insurance.
- lunchladydoris 10y agoPeople shouldn't have a supply for use when they feel like it. Antibiotics are a last resort, not first! If someone has some left over then they did not finish the previous course, which means that they have potentially allowed the strongest bacteria from the previous illness to live on. Maybe it's not common knowledge, but taking antibiotics is essentially putting evolution into overdrive. At first you kill off the weakest bacteria and then only later the most able to survive. If someone ends their course early, they are allowing the best adapted bacteria to live on and multiply. Perhaps the person wouldn't be getting sick the second time if they had finished their course in the first place. Also, taking antibiotics also does harm to a person's own flora, not just the invaders. So, please don't take antibiotics if you don't need them, and finish them when you do need to. Edit: removed extra 'not' in first paragraph.
- 10y ago
- adventured 10y agoThis premise is going to turn out to be entirely incorrect. There's a wave of therapeutic approaches to antibiotic resistance coming in the next 10-15 years, courtesy of CRISPR (gene editing broadly). We're going to end up having hundreds of new experimental angles of attack at resistance and infection. In fact, by far the bigger problem, is going to be narrowing down the vast array of options of attack that CRISPR is going to unleash. These articles repeating the same hyped up fear, are missing what's right around the corner (which usually happens with such statements of doom, ala the world running out of food claims from decades ago). And best of all it's going to be inexpensive, relatively speaking, and extremely fast paced, to make progress in that direction. Cas9 and its superior alternatives such as Cpf1 arrived just in time.
- Fomite 10y agoI sincerely hope this is true, but 10-15 years ago high throughput computational screening was going to usher in a new wave of targets and molecules that acted against them, and we were going to unlock who new families of antimicrobials.
- umberway 10y ago>These articles repeating the same hyped up fear Yes! Antibiotics (as an issue) are now associated with guilt and hubris. I trust CRISPR technologies will yield new weapons to fight infections and other diseases.
- stefantalpalaru 10y ago> courtesy of CRISPR That's not how it works. Gene editing is unlikely to help us discover new antibiotics and that's what we need, not ways to manufacture them at scale. We already have those.
- csl 10y agoAlexander Fleming gave the following warning, way back in his 1945 Nobel speech: It is not difficult to make microbes resistant to penicillin in the laboratory by exposing them to concentrations not sufficient to kill them, and the same thing has occasionally happened in the body. From page 93 in https://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/fleming-lecture.pdf https://www.nobelprize.org/nobel_prizes/medicine/laureates/1... BBC did a very good radio segment about the penicillin discovery in their "50 Things That Made the Modern Economy" radio series: http://www.bbc.co.uk/programmes/p04pfn2z http://www.bbc.co.uk/programmes/p04pfn2z
- jakobegger 10y agoA few important points about antibiotic resistance (as far as understood by a lay person that likes to read articles on the topic): 1) Resistance is inevitable. It doesn't matter if everyone finishes their prescribed treatment or not, bacteria will develop resistance to antibiotics one way or another. 2) Antibiotic resistance comes at a cost to the bacteria. In the absence of antibiotics, bacteria will lose their resistance. It is pretty unlikely that you will get infected with antibiotic-resistant bacteria when you bruise your knee in the dirt. 3) Multi-resistant bacterial infections mostly occur in a clinical setting, where people are especially vulnerable to infections (people on a respirator, people with a central venous line). You can prevent multi-resistant infections just like you prevent normal infections: Use sterile gloves, isolate people, follow procedure protocols precisely, etc. Multi-resistant pathogens are a problem, but it's far from the doomsday scenario painted in those "it's the end of antibiotics" articles.
- morsch 10y agoPoints 1 and 2 seem contradictory.
- WildUtah 10y agoIf you could ban an antibiotic, bacteria would lose their resistance to it in time. Resistance consumes a lot of energy and the bacteria without it would simply outcompete the resistant varieties to quick extinction in a few thousand or million generations. But as long as people keep using the antibiotic, the bacteria will continue getting more resistant.
- edem 10y agoIt is not. Basically it says: "bacteria will get resistant with prolonged exposure, but lose resistance when they are no longer exposed."
- piratelax40 10y agobe very careful about semantics, the statement is: bacteria will become resistant overtime when exposed to antibotics at concentrations insufficient to kill all of them, however when removing the selective pressure of antibiotics, they will "lose" resistance as that selective pressure is no longer applied. As the poster above mentioned, energetically, resistance to antibiotics is costly, as bacteria will do things like increase the number of efflux pumps in their cell membranes pumping out antibiotics. When there are plenty of nutrients available as other strains have died, this is an acceptable tradeoff, however without that pressure, the strains with less defense mechanisms, but also need less nutrients to survive, will again outcompete and become dominant. Finally, just to reiterate, it is exposure at levels not high enough to kill all strains that causes resistance development. If you maintain concentrations so high that no strains can survive, resistance will never develop. Unfortunately, this is virtually impossible in practice, as adverse safety events would also occur too frequently at those 'scorched earth' levels.
- sengork 10y agoFor those that would like to visualise how the bacteria vs anitbiotics evolve in an experiment over 11 days, have a look at this video from Harvard: https://www.youtube.com/watch?v=plVk4NVIUh8 https://www.youtube.com/watch?v=plVk4NVIUh8
- diminoten 10y agoI've never really bought these doomsday scenario claims, if only because I feel like innovation is constantly taking place, and these projections necessarily assume no new innovations (how could they predict innovation, after all?).
- Hondor 10y agoI agree. Furthermore, now that people are accustomed to not dieing all the time, even with no new technology, we would probably tolerate more serious measures to maintain this safety. Even if it came to draconian quarantine and hygene laws, or just wearing a face mask every day. Remember how Ebola didn't cause an epidemic in any moderately developed country despite being one of the easiest diseases to transmit?
- manarth 10y agoEbola didn't cause an epidemic in any moderately developed country despite being one of the easiest diseases to transmit? Ebola isn't airborne, and an infected person isn't contagious until they start to present symptoms. Although it's a very serious disease, its presentation makes an outbreak relatively easy to recognise and control.
- botexpert 10y agoIt's such a shame we used them all on livestock. We raise around 60 billion land animals every year and probably more than 90% is being given last-line-of-defense antibiotics for faster growth. Perfect pool for some unbelievable evolution of antibiotic resistant bacteria, and yet we want to ban antibacterial soaps and other minor things. But, at least the stakes and muttons and whatevz can be enjoyed.
- nickhalfasleep 10y agoAnother reason to grow laboratory meat in rooms so clean they do not need antibiotics. Do not need antibiotics. Less water to consume. Less energy to produce. Can be situated closer to populations who consume it. *Cruelty free.
- grahamm 10y agoThe problem is anti-biotics are no longer being developed. They could be developed but it is not finicially worth a large pharma to do so. Consider this, development takes years (>10) and costs billions due to failed attempts (over 9 in 10 fail), testing, etc. They then go to market and no government will buy them because the price is high to recoup the billions spent developing over ten drugs which only one made to market. In the end the governments force the companies to sell them at a loss should there be an epidemic. Then to cap it all some company in another part of the world where IP is not honoured rips off the drug and floods the most needed places with a cheap knock off. Where is the incentive for a pharma to go through this.
- d33 10y agoHow could the costs be driven down? Perhaps it's because FDA is overly cautious?
- grahamm 10y agoAnd before the FDA is over cautious the pharma is cautious. If they pushed a drug through that didn't work or caused serious side effects there would be legal implications that would wipe out some or all financial gains from the drug. Back to having no incentive.
- necessity 10y agoThe woman died because the antibiotic that could save her life was not approved in the US by the FDA, not because there was no anti-biotic that could possibly save her. https://www.theatlantic.com/health/archive/2017/01/a-superbug-resistant-to-26-antibiotics-killed-a-woman-itll-happen-again/513050/ https://www.theatlantic.com/health/archive/2017/01/a-superbu...
- chrisgd 10y agoHow are we able to create vaccines against bacteria and why couldn't we do it for more strains i.e.,MRSA? My son spent some time in the hospital fighting a pneumonia. Now his doctors are looking into why his body didn't get immunity from the pneumococcal vaccine (Prevnar13). I was always under the impression only viruses could be immunized against.
- known 10y agoCan we use a virus that eats/kills that bacteria and later we'll kill that virus.
- stefantalpalaru 10y agoWe're not going to solve this by allowing pharmaceutical companies to extract a bigger profit. That would be a perverse incentive that would result in a slower progress and reduced therapeutic availability - specially in countries where access to healthcare is conditioned by personal wealth. What we need to do is artificially create competition by funding state-owned pharmaceutical companies and redirecting all that publicly funded academic research towards them. We can even take a loss, because the overall benefits outweigh profitability.
- Ericson2314 10y agoHonestly drug bounties seems so much better than patents across the board. Patents are better when you're inventing the market too, but even then are no panacea as it may take a long time to build the market after the initial invention, eating into the patterns lifespan. True innovative is often bewildered. Here not only is the market clear cut, but this benefits new entrents as the immediate windfall allows for more risk-taking. It's liquidity for innovation. Finally, the costs for patients / emergencies can be dirt-cheap, which is good because just as one should have insurance to cover future emergencies, so should society budge the R&D up-front.
- thephyber 10y agoThis was the subject of this week's "50 Things that Made the Modern Economy", a BBC podcast: http://www.bbc.co.uk/programmes/p04pfn2z http://www.bbc.co.uk/programmes/p04pfn2z
- jvanderbot 10y agohttps://www.hhs.gov/about/news/2016/07/28/hhs-forges-unprecedented-partnership-combat-antimicrobial-resistance.html https://www.hhs.gov/about/news/2016/07/28/hhs-forges-unprece... HHS has a joint initiative with UK-based research foundations. I really wish an easy non-profit foundation existed that I could throw some change at. Here's some more information: http://www.openphilanthropy.org/research/cause-reports/antibiotic-resistance http://www.openphilanthropy.org/research/cause-reports/antib...
- marktuff1 10y agoDoesn't it strike anyone that perhaps of constantly trying to kill everything in sight that perhaps we should figure out a way to add super pro-biotics to our micro-biome to create little beneficial bacteria armies to fight the war against bugs instead of nuking our whole flora which then results in zero immunity and ability to fight anything off.
- mtdewcmu 10y agoAn even more direct way for the government to push discovery of new antibiotics would be for the government to do the R&D itself. Of course, that would offend certain ideologues.
- A_Crazy_Idea 10y agoThe real problem with Medicine is there are too many frauds practicing it. Until that is addressed, nothing can be done. It's like telling people to drive less on the weekend while 800,000 ton cargo boats cross the Atlantic. What is this article really selling? More profit margin for large research firms. Somehow, that doesn't seem like the solution.
- ivanceras 10y agoWait until enough people are sick or dying at the same time to impact the economy or some high ranking politician finds his dicks rotting away from an untreatable STD and they'll soon plough money into the problem.